Chronic Eczema on Arms due to Aluminum Vaccine Resolved with Dupilumab

Abstract

Get full access to this article

View all access options for this article.

References

Goldminz

, Scheinman

. A case series of dupilumab-treated allergic contact Dermatitis® patients. Dermatol Ther, 2018; 31(6):e12701. doi: 10.1111/dth.12701

Bruze

, Netterlid

, Siemund

. Aluminum-allergen of the year 2022. Dermatitis®, 2022; 33(1):10–15. doi: 10.1097/DER.0000000000000836

Lidholm

, Inerot

, Gillstedt

, et al. Long-term clinical course and prognosis of vaccine-related persistent itching nodules (1997–2019): An observational study. Vaccine X, 2022; 11:100163. doi: 10.1016/j.jvacx.2022.100163

Docampo-Simón

, Sánchez-Pujol

, Pastor-Nieto

, et al. Patch testing in patients with severe atopic Dermatitis® treated with dupilumab: A multicentric approach in Spain. Dermatitis®, 2023; 34(4):315–322. doi: 10.1089/derm.2022.0023

Goldminz

, Scheinman

. A case series of dupilumab-treated allergic contact Dermatitis® patients. Dermatol Ther, 2018; 31(6):e12701. doi: 10.1111/dth.12701